ARCHIVES

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

This article is from The Cancer Letter archive.

Vol. 20 No. 39 | October 14, 1994

Download PDF Visit The Full Archive

Related Articles

Payline Not Set For CCOPs Yet In Recompetition

March 1, 1991

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

National Action Plan: Steering committee Votes No Confidence In HHS Official.

August 15, 1997

In Brief: Hew Finally Okays New NIH Study Section For Chemical, Environmental Carcinogenesis

March 16, 1979

DCPC Board Okays Recompetition Of Computer Contract

May 30, 1986